InVivoMAb mouse IgG2b isotype control, unknown specificity

Turnis ME, Sawant DV, Szymczak-Workman AL, et al. Interleukin-35 Limits Anti-Tumor Immunity. Immunity. 2016,44(2):316-29. doi: 10.1016/j.immuni.2016.01.013

Barreira da Silva R, Laird ME, Yatim N, et al. Dipeptidylpeptidase 4 inhibition enhances lymphocyte trafficking, improving both naturally occurring tumor immunity and immunotherapy. Nat Immunol. 2015,16(8):850-8. doi: 10.1038/ni.3201

Le Saout C, Hasley RB, Imamichi H, et al. Chronic exposure to type-I IFN under lymphopenic conditions alters CD4 T cell homeostasis. PLoS Pathog. 2014,10(3):e1003976. doi: 10.1371/journal.ppat.1003976

Larena M, Regner M, Lee E, et al. Pivotal role of antibody and subsidiary contribution of CD8+ T cells to recovery from infection in a murine model of Japanese encephalitis. J Virol. 2011,85(11):5446-55. doi: 10.1128/JVI.02611-10

Lamere MW, Moquin A, Lee FE, et al. Regulation of antinucleoprotein IgG by systemic vaccination and its effect on influenza virus clearance. J Virol. 2011,85(10):5027-35. doi: 10.1128/JVI.00150-11